Preeclampsia in low and middle income countries-health services lessons learned from the PRE-EMPT (PRE-Eclampsia-Eclampsia Monitoring, Prevention and Treatment) project
von Dadelszen, P.; Firoz, T.; Donnay, F.; Gordon, R.; Justus Hofmeyr, G.; Lalani, S.; Payne, B.A.; Roberts, J.M.; Teela, K.C.; Vidler, M.; Sawchuck, D.; Magee, L.A.
Journal of Obstetrics and Gynaecology Canada Jogc 34(10): 917-926
2012
ISSN/ISBN: 1701-2163 PMID: 23067947 Document Number: 623364
The hypertensive disorders of pregnancy, in particular preeclampsia, matter because adverse events occur in women with preeclampsia and, to a lesser extent, in women with the other hypertensive disorders. These adverse events are maternal, perinatal, and neonatal and can alter the life trajectory of each individual, should that life not be ended by complications. In this review we discuss a number of priorities and dilemmas that we perceive to be facing health services in low and middle income countries as they try to prioritize interventions to reduce the health burden related to preeclampsia. These priorities and dilemmas relate to calcium for preeclampsia prevention, risk stratification, antihypertensive and magnesium sulphate therapy, and mobile health. Significant progress has been and is being made to reduce the impact of preeclampsia in low and middle income countries, but it remains a priority focus as we attempt to achieve Millennium Development Goal 5.